FR940303-2-00058 FR940303-2-00044 [Docket No. 94N&hyph;0021] Schering-Plough Corp.; Withdrawal of Approval of NADA AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA) held by Schering-Plough Corp. The NADA provides for the use of Variton (diphemanil methylsulfate) Cream 2 percent. The firm requested the withdrawal of approval. EFFECTIVE DATE: March 14, 1994. FOR FURTHER INFORMATION CONTACT: Dianne T. McRae, Center for Veterinary Medicine (HFV&hyph;102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1623. SUPPLEMENTARY INFORMATION: Schering-Plough Animal Health, Schering-Plough Corp., P.O. Box 529, Kenilworth, NJ 07033, is the sponsor of NADA 9&hyph;997 for Variton (diphemanil methylsulfate) Cream 2 percent for topical use on dogs and cats. By a letter dated November 15, 1993, Schering-Plough Corp. requested withdrawal of approval of the NADA because it no longer manufactures or distributes the product. Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with ยง514.115 Withdrawal of approval of applications (21 CFR 514.115), notice is given that approval of NADA 9&hyph;997 and all supplements and amendments thereto is hereby withdrawn, effective March 14, 1994. Dated: February 23, 1994. Richard H. Teske, Acting Director, Center for Veterinary Medicine [FR Doc. 94&hyph;4799 Filed 3&hyph;2&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
